Earnings
CRSP
169.53
-6.46%
-11.71
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
289.59M
289.59M
--
--
63.49M
179.36M
--
--
--
242.85M
--
46.74M
-5.47M
--
26.03M
-5.47M
67.31M
448.00K
66.86M
--
66.86M
66.86M
--
--
1.17
FY 2018-12-31
3.12M
3.12M
--
--
48.29M
113.77M
--
--
--
162.07M
--
-158.94M
-4.28M
--
-1.21M
-4.28M
-164.43M
553.00K
-164.98M
0.00
-164.98M
-164.98M
--
--
-3.44
FY 2017-12-31
41.00M
41.00M
--
--
35.84M
69.80M
--
--
--
105.64M
--
-64.65M
-1.76M
--
-197.00K
-1.76M
-66.61M
1.75M
-68.36M
0.00
-68.36M
-68.36M
-6.30M
--
-1.71
FY 2016-12-31
5.16M
5.16M
--
--
31.06M
42.24M
--
--
--
61.81M
--
-56.65M
-44.58M
--
78.51M
-44.58M
-22.72M
484.00K
-23.20M
25.00K
-23.18M
-23.18M
--
--
-1.89
FY 2015-12-31
247.00K
247.00K
--
--
13.40M
12.57M
--
--
--
25.98M
--
-25.73M
-108.00K
--
16.00K
-108.00K
-25.82M
7000.00
-25.83M
325.00K
-25.50M
-25.50M
--
--
-0.64

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CRSP latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Crispr Therapeut recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.